ATE369564T1 - Differenzielles immunoassay für myoglobin - Google Patents

Differenzielles immunoassay für myoglobin

Info

Publication number
ATE369564T1
ATE369564T1 AT01963291T AT01963291T ATE369564T1 AT E369564 T1 ATE369564 T1 AT E369564T1 AT 01963291 T AT01963291 T AT 01963291T AT 01963291 T AT01963291 T AT 01963291T AT E369564 T1 ATE369564 T1 AT E369564T1
Authority
AT
Austria
Prior art keywords
analyte
source
level
sample
assay
Prior art date
Application number
AT01963291T
Other languages
English (en)
Inventor
Qinwei Shi
Original Assignee
Spectral Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectral Diagnostics Inc filed Critical Spectral Diagnostics Inc
Application granted granted Critical
Publication of ATE369564T1 publication Critical patent/ATE369564T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/972—Modified antibody, e.g. hybrid, bifunctional
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT01963291T 2000-08-24 2001-08-24 Differenzielles immunoassay für myoglobin ATE369564T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22753600P 2000-08-24 2000-08-24
US29249701P 2001-05-21 2001-05-21
US09/938,270 US6673562B2 (en) 2000-08-24 2001-08-23 Differential immunoassay

Publications (1)

Publication Number Publication Date
ATE369564T1 true ATE369564T1 (de) 2007-08-15

Family

ID=27397733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01963291T ATE369564T1 (de) 2000-08-24 2001-08-24 Differenzielles immunoassay für myoglobin

Country Status (5)

Country Link
US (3) US6673562B2 (de)
EP (1) EP1386164B1 (de)
AT (1) ATE369564T1 (de)
DE (1) DE60129855D1 (de)
WO (1) WO2002016943A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60233107D1 (de) * 2002-01-09 2009-09-10 Inverness Medical Switzerland Teststreifen enthaltend Kontrollmittel und Zeitsetzermittel
JP2007518062A (ja) * 2003-09-29 2007-07-05 バイオサイト インコーポレイテッド 敗血症を診断する方法および診断するための組成物
US20050148029A1 (en) * 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
US20050196817A1 (en) * 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
WO2006031216A1 (en) * 2004-09-10 2006-03-23 Metrika, Inc. Quantitative immunoassays using tag/anti-tag chemistry
US20080050832A1 (en) * 2004-12-23 2008-02-28 Buechler Kenneth F Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
CA2624569A1 (en) * 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
CN100367034C (zh) * 2005-10-20 2008-02-06 上海交通大学 免疫胶体金粒子荧光淬灭的测量方法
WO2008030546A2 (en) * 2006-09-06 2008-03-13 Ouantrx Biomedical Corporation Lateral flow test strip with migrating label
EP1956096A1 (de) * 2007-02-12 2008-08-13 Université Catholique de Louvain Verfahren, Vorrichtung und Kit zur Bestimmung der mit einer Dysfunktion des renalen proximalen Tubulus verbundenen Leiden
US20090004755A1 (en) * 2007-03-23 2009-01-01 Biosite, Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
US8221995B2 (en) * 2007-03-23 2012-07-17 Seok-Won Lee Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
WO2009027514A1 (en) * 2007-08-30 2009-03-05 Roche Diagnostics Gmbh Means and methods for the discrimination of gdf-15 elevation related or unrelated to cardiac disorders
WO2010129265A2 (en) * 2009-04-27 2010-11-11 The Research Foundation Of State University Of New York Compositions comprising monomeric streptavidin and methods for using same
DK3684949T3 (en) 2017-09-22 2024-07-08 Univ Washington In situ combinatorial labeling of cellular molecules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857453A (en) 1987-04-07 1989-08-15 Syntex (U.S.A.) Inc. Immunoassay device
US4900662A (en) 1987-07-21 1990-02-13 International Immunoassay Laboratories, Inc. CK-MM myocardial infarction immunoassay
US4952517A (en) 1988-02-08 1990-08-28 Hygeia Sciences, Inc. Positive step immunoassay
US5851527A (en) * 1988-04-18 1998-12-22 Immunomedics, Inc. Method for antibody targeting of therapeutic agents
ES2088427T3 (es) 1989-03-21 1996-08-16 Hygeia Sciences Ltd Ensayo simultaneo de dos analitos.
GB8916718D0 (en) 1989-07-21 1989-09-06 Vioclone Biolog Inc Use of creatine kinase and its isozyme ck-mb and human ventricular myosin light chain 1 in the diagnosis of heart failure
CA2027434C (en) 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
US5604105B1 (en) 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
US5710008B1 (en) 1990-10-12 1999-09-07 Spectral Diagnostics Inc Method and device for diagnosing and distinguishing chest pain in early onset thereof
SE9101735D0 (sv) 1991-06-07 1991-06-07 Pharmacia Biosensor Ab Method and sensor means for determining myocardial infarction markers
CN1123771C (zh) * 1996-06-11 2003-10-08 财团法人工业技术研究院 一种急性心肌梗塞检测试剂盒
ATE237807T1 (de) * 1998-08-06 2003-05-15 Spectral Diagnostics Inc Analytisches testgerät und verfahren
DE19859912C2 (de) * 1998-12-23 2001-06-21 Aventis Res & Tech Gmbh & Co Testsystem zur Erkennung verschiedener Marker, seine Herstellung sowie Verwendung

Also Published As

Publication number Publication date
US20050260689A1 (en) 2005-11-24
EP1386164B1 (de) 2007-08-08
US6673562B2 (en) 2004-01-06
WO2002016943A3 (en) 2003-10-23
WO2002016943A2 (en) 2002-02-28
EP1386164A2 (de) 2004-02-04
US20020177241A1 (en) 2002-11-28
DE60129855D1 (de) 2007-09-20
US20080311591A1 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
DE60129855D1 (de) Differenzielles immunoassay für myoglobin
DE69928809D1 (de) Differentielle diagnose von neurodegeneration
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
WO2003008933A3 (en) Test strip for a lateral flow assay
MY134148A (en) Multi-layer reagent test strip
ATE509275T1 (de) Schnelltest für glykiertes albumin
AU2002359891A1 (en) Test strip for determining concentration of triglycerides
DE60228684D1 (de) System zur überwachung der konzentration von analyten in körperflüssigkeiten
MXPA02007420A (es) Metodos y dispositivos para utilizarse en estudios para determinar la concentracion de analitos.
CA2519504C (en) Combination assay for alcohol and drugs of abuse
MX2009006205A (es) Inmunoensayo de multiples analitos.
TW200613729A (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
DE60130919D1 (de) Durchflussvorrichtung, diagnostischer kit diese enthaltend und gebrauch für den nachweis von analyten in einer probe
JP4292080B2 (ja) Ｓ１００ｂの測定による敗血症の診断方法
KR960705211A (ko) 체액내 bpi의 정량 방법(method for quantifying bpi in body fluids)
Pugia et al. Clinical utility of a rapid test for uristatin
ATE551598T1 (de) Fluorimetrische bestimmung von analyten durch ein intramolekulares quencher-fluorophor-konjugat
JP4272065B2 (ja) Ｃａ１２５の測定による敗血症の検出方法
JP2005512058A (ja) Ｃａ１９−９の測定による敗血症の診断方法
BR9913770A (pt) Processo de ensaio para determinação da cobalamina ligada a transcobalamina ii (tcii) em uma amostra de corpo, kit para uso em um ensaio diagnóstico, e, uso de holo-tc ii
EP1947459A3 (de) Differential-Immunoassay
Wicaksono et al. Cotton fiber-based assay with time-based microfluidic absorption sampling for point-of-care applications
MY106963A (en) Agglutination assay.
US20190324018A1 (en) Saliva reagent strip for detecting concentration of pepsin or pepsinogen
ATE322687T1 (de) Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties